BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8900208)

  • 1. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
    Zhang X; Chen ZQ; Wang Z; Mohan W; Tam SP
    J Biol Chem; 1996 Oct; 271(43):27152-60. PubMed ID: 8900208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human apolipoprotein A-I gene expression by gramoxone.
    Cuthbert C; Wang Z; Zhang X; Tam SP
    J Biol Chem; 1997 Jun; 272(23):14954-60. PubMed ID: 9169468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
    Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
    J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
    Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
    J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human apolipoprotein A-I gene expression by equine estrogens.
    Zhang X; Jiao JJ; Bhavnani BR; Tam SP
    J Lipid Res; 2001 Nov; 42(11):1789-800. PubMed ID: 11714848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
    Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
    Jin FY; Kamanna VS; Chuang MY; Morgan K; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B.
    Tam SP
    Atherosclerosis; 1991 Nov; 91(1-2):51-61. PubMed ID: 1811554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine.
    Wu JY; Zhang JJ; Wang Y; Reaves SK; Wang YR; Lei PP; Lei KY
    Am J Physiol; 1997 Oct; 273(4):C1362-70. PubMed ID: 9357782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
    Saladin R; Vu-Dac N; Fruchart JC; Auwerx J; Staels B
    Eur J Biochem; 1996 Jul; 239(2):451-9. PubMed ID: 8706754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chromium on apolipoprotein A-I expression in HepG2 cells.
    Haas MJ; Sawaf R; Horani MH; Gobal F; Wong NC; Mooradian AD
    Nutrition; 2003 Apr; 19(4):353-7. PubMed ID: 12679171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding specificity and modulation of the ApoA-I promoter activity by homo- and heterodimers of nuclear receptors.
    Tzameli I; Zannis VI
    J Biol Chem; 1996 Apr; 271(14):8402-15. PubMed ID: 8626539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines.
    Mooradian AD; Haas MJ; Wadud K
    Metabolism; 2006 Feb; 55(2):159-67. PubMed ID: 16423621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein.
    Cardot P; Pastier D; Lacorte JM; Mangeney M; Zannis VI; Chambaz J
    Biochemistry; 1994 Oct; 33(40):12139-48. PubMed ID: 7918435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
    Harnish DC; Malik S; Karathanasis SK
    J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bifunctional regulatory element of the human ApoA-I gene responsive to a distal enhancer.
    Jones DR; Leffak M
    DNA Cell Biol; 1999 Feb; 18(2):107-19. PubMed ID: 10073570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of apolipoprotein A-I gene expression by phenobarbital in the human hepatocarcinoma cell line, Hep3B.
    Tam SP; Deeley RG
    Atherosclerosis; 1994 Feb; 105(2):235-43. PubMed ID: 8003099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor.
    Haas MJ; Reinacher D; Li JP; Wong NC; Mooradian AD
    J Mol Endocrinol; 2001 Aug; 27(1):43-57. PubMed ID: 11463575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARĪ³ in HepG2 cells.
    Du Y; Wang L; Si S; Yang Y; Hong B
    Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.